Clinical Trials
20
Trial Phases
3 Phases
Drug Approvals
2
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (17 trials with phase data)β’ Click on a phase to view related trials
Dose Ranging Study of Metronidazole Vaginal Gel in the Treatment of Bacterial Vaginosis
- Conditions
- Vaginosis, BacterialVaginal Infection
- Interventions
- Drug: GW05
- First Posted Date
- 2010-01-25
- Last Posted Date
- 2011-07-01
- Lead Sponsor
- Graceway Pharmaceuticals, LLC
- Target Recruit Count
- 255
- Registration Number
- NCT01055106
- Locations
- πΊπΈ
Women's Health Research, Phoenix, Arizona, United States
πΊπΈPrecision Trials, Phoenix, Arizona, United States
πΊπΈNEA Women's Clinic, Jonesboro, Arkansas, United States
Safety and Effectiveness Study of Actinic Keratosis Treatment Following Cryosurgery
- First Posted Date
- 2009-05-07
- Last Posted Date
- 2010-08-31
- Lead Sponsor
- Graceway Pharmaceuticals, LLC
- Target Recruit Count
- 247
- Registration Number
- NCT00894647
- Locations
- πΊπΈ
Dermatology Research Associates, Los Angeles, California, United States
πΊπΈTherapeutics Clinical Research, San Diego, California, United States
πΊπΈSpencer Dermatology & Skin Surgery Center, St. Petersberg, Florida, United States
Phase 3 Study of Imiquimod Creams in the Treatment of External Genital Warts
- Conditions
- Genital Warts
- Interventions
- First Posted Date
- 2008-08-15
- Last Posted Date
- 2011-07-20
- Lead Sponsor
- Graceway Pharmaceuticals, LLC
- Target Recruit Count
- 511
- Registration Number
- NCT00735462
- Locations
- πΊπΈ
NEA Clinic, Jonesboro, Arkansas, United States
πΊπΈNorthern Claifornia Research, Carmichael, California, United States
πΊπΈCalifornia State University - Chico, Chico, California, United States
Safety and Effectiveness Study of Imiquimod Creams in the Treatment of External Genital Warts
- Conditions
- Genital Warts
- Interventions
- First Posted Date
- 2008-05-08
- Last Posted Date
- 2011-05-24
- Lead Sponsor
- Graceway Pharmaceuticals, LLC
- Target Recruit Count
- 470
- Registration Number
- NCT00674739
- Locations
- πΊπΈ
WILMAX Clinical Research, Mobile, Alabama, United States
πΊπΈMontgomery Women's Health Associates, Montgomery, Alabama, United States
πΊπΈWomen's Health Research, Phoenix, Arizona, United States
Follow-up Study to Evaluate Sustained Clearance Rates of Actinic Keratoses up to One Year
- Conditions
- Actinic Keratoses
- First Posted Date
- 2008-04-29
- Last Posted Date
- 2010-07-20
- Lead Sponsor
- Graceway Pharmaceuticals, LLC
- Target Recruit Count
- 179
- Registration Number
- NCT00668733
- Prev
- 1
- 2
- 3
- 4
- Next